Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Ageing populations: the challenges ahead
2009 Standout
The global burden of diabetic foot disease
2005 Standout
Diabetes Mellitus Is a Risk Factor for Vascular Dementia, but Not for Alzheimer’s Disease: A Population-Based Study of the Oldest Old
2002
Year of Diagnosis, Features at Presentation, and Risk of Recurrence in Patients with Pheochromocytoma or Secreting Paraganglioma
2005
Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
2012 Standout
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?
2003
Obesity and Diabetes in the Developing World — A Growing Challenge
2007 Standout
Pheochromocytoma as an Endocrine Emergency
2003
Adrenal pheochromocytoma remains a frequently overlooked diagnosis
2000
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Phaeochromocytoma
2005 Standout
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
2013 Standout
Hereditary paraganglioma targets diverse paraganglia: Table 1
2002
Perioperative management of pheochromocytoma
2002
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients
2005
Comparison of phenoxybenzamine to sodium nitroprusside in infants undergoing surgery
2005
Oxygen sensing by HIF hydroxylases
2004 StandoutNobel
The management of benign and malignant pheochromocytoma and abdominal paraganglioma
2003
Phaeochromocytoma—recent progress in its management
2000
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
2016 StandoutNobel
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Surgical Management of Pheochromocytoma with the Use of Metyrosine
1990
Pheochromocytoma in Italy: a multicentric retrospective study
1999
Diabetic Retinopathy
2012 Standout
Diabetes in Asia
2009 Standout
Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986-2009
2010
Diabetes and Atherosclerosis
2002 Standout
Capture-recapture method to estimate lower extremity amputation rates in Rio de Janeiro, Brazil
2001
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
2012 Standout
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Oxidation of myosin heavy chain and reduction in force production in hyperthyroid rat soleus
2006
Prevalence of Diabetes among Men and Women in China
2010 Standout
Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden
2008
Chronic kidney disease: global dimension and perspectives
2013 Standout
Worldwide access to treatment for end-stage kidney disease: a systematic review
2015 Standout
Diabetic foot ulcers
2003 Standout
Type 1 diabetes
2013 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Projections of Global Mortality and Burden of Disease from 2002 to 2030
2006 Standout
Obesity and the Regulation of Energy Balance
2001 Standout
Risk of dementia in diabetes mellitus: a systematic review
2005 Standout
Benign Paragangliomas: Clinical Presentation and Treatment Outcomes in 236 Patients
2001
Pheochromocytoma: Update on Diagnosis, Localization, and Management
1995
The Global Burden of Chronic Diseases
2004 Standout
Mortality associated with pheochromocytoma in a large Swedish cohort
2004
The value of plasma markers for the clinical behaviour of phaeochromocytomas
2002
Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland
2000
Prediabetes: a high-risk state for diabetes development
2012 Standout
Diabetes as a marker of pheochromocytoma in hypertensive patients
2003
Death from Phaeochromocytoma: Lessons from a Post-Mortem Survey
1995
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Identification of Novel Autoantibodies in Type 1 Diabetic Patients Using a High-Density Protein Microarray
2014
Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
2013 Standout
Hormones, Receptors, and Cyclic AMP: Their Role in Target Cell Refractoriness
1980 StandoutNobel
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Diagnosis of Pheochromocytoma
1988
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
2015 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Beta adrenergic receptors in lymphocyte subpopulations
1980 StandoutNobel
Direct Demonstration of Impaired Functionality of a Purified Desensitized β-Adrenergic Receptor in a Reconstituted System
1984 StandoutScienceNobel
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Thermogenic response to epinephrine in the forearm and abdominal subcutaneous adipose tissue
1992
Platelet Dysfunction in Type 2 Diabetes
2001
β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?
2013
Global Prevalence of Diabetes
2004 Standout
Pheochromocytoma: State-of-the-Art and Future Prospects
2003
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Tumor Recurrence and Hypertension Persistence After Successful Pheochromocytoma Operation
1997
Functional integrity of desensitized beta-adrenergic receptors.
1983 StandoutNobel
Extra-Adrenal Pheochromocytoma
1992
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mechanisms of Diabetic Complications
2013 Standout
Diagnostic Evaluation of Pheochromocytoma
1988
Corticosteroid-Induced Differential Regulation of β-Adrenergic Receptors in Circulating Human Polymorphonuclear Leukocytes and Mononuclear Leukocytes*
1980 StandoutNobel
Benign and Malignant Pheochromocytoma
1998
Phaeochromocytoma with Normal Urinary Catecholamines: The Potential Value of Urinary Free Metadrenalines
2002
Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model
1985 StandoutNatureNobel
Diabetes mellitus and risk of dementia in the Kungsholmen project
2004
Cellular and molecular basis of wound healing in diabetes
2007 Standout
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
1990 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Fat cell adrenergic receptors and the control of white and brown fat cell function
1993
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Gunnar Stenström being referenced
QRS Amplitudes, QTc Intervals and ECG Abnormalities in Pheochromocytoma Patients before, during and after Treatment
1988
Long‐term Results in 64 Patients Operated Upon for Pheochromocytoma
1988
The Prevalence of Diabetes in a Swedish Population of 280,411 Inhabitants: A report from the Skaraborg Diabetes Registry
1998
Studies on the catecholamine resistance in fat cells from patients with phaeochromocytoma
1977
Influence of Pre‐operative Treatment with Phenoxybenzamine on the Incidence of Adverse Cardiovascular Reactions during Anaesthesia and Surgery for Phaeochromocytoma
1985
Evaluation of Platelet Reactivity in Diabetes Mellitus
1986
Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data.
1986
Latent Autoimmune Diabetes in Adults
2005
Pheochromocytoma in Sweden 1958–1981
1986
Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry.
1999
Positive Correlation between Urinary Excretion of Catecholamine Metabolites and Tumour Mass in Pheochromocytoma
1985
Excretion of Adrenaline, Noradrenaline, Vanilmandelic Acid and Metanephrines in 64 Patients with Pheochromocytoma
1983
Diabetes mellitus in phaeochromocytoma Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma
1984
Multiple neuroectodermal abnormalities in pheochromocytoma patients
1988
Results from a Prospective, Randomized Study
1987
Urinary excretion of 3-methylhistidine and creatinine and plasma concentrations of amino acids in hyperthyroid patients following preoperative treatment with antithyroid drug or β-blocking agent: Results from a prospective, randomized study
1987
The Blood Volume in Pheochromocytoma Patients before and during Treatment with Phenoxybenzamine
1985